ASTS
AST SpaceMobile, Inc.
ASTS trails on the overall score without a compensating advantage in the available component scores.
FATN
FatPipe, Inc. Common Stock
FATN has the edge over ASTS overall, supported by stronger valuation.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
FATN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Unavailable | |
| Healthy |
FATN's revenue, profitability and balance sheet are currently healthy. There isn't enough data to rate its cash flow.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
FATN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.7x | $4.67 | — |
| Cheap | 14x | $6.89 | +47% |
| Fair | 25x | $12.09 | +159% |
| Expensive | 45x | $21.56 | +362% |
Historical ranges are pointers, not guarantees.
FATN's PE is in its cheap range at 9.7x.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
FATN Forward outlook
There aren't enough analyst estimates for FATN to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
FATN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.48 | +700% |
| Q2 2026 | $0.39 | +255% |
| Q1 2026 | $0.35 | +218% |
| Q4 2025 | $0.08 | -71% |
| Q3 2025 | $0.06 | -81% |
FATN has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over FATN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
FATN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.8M | +22% |
| Q2 2026 | $5M | +28% |
| Q1 2026 | $13.6M | +330% |
| Q4 2025 | $4.1M | +30% |
| Q3 2025 | $4M | +5.6% |
| Q2 2025 | $3.9M | +4.9% |
| Q1 2025 | $3.1M | -41% |
| Q4 2024 | $3.1M | -21% |
FATN's revenue has grown year over year for six quarters in a row: $5M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +18 points |
| Q2 2026 | 18% | -7.6 points |
| Q1 2026 | 16% | +10 points |
| Q4 2025 | 9.8% | +4 points |
| Q3 2025 | 0% | -23 points |
| Q2 2025 | 25% | +2.6 points |
| Q1 2025 | 5.9% | -39 points |
| Q4 2024 | 5.9% | -20 points |
FATN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has the stronger cash trend. Its trailing FCF is down 363% versus its history, compared with FATN at down 1,053%.
FATN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$679K | -$128K |
| Q4 2025 | $240.9K | +$363.6K |
| Q3 2025 | $399.8K | +696% |
| Q2 2025 | -$551.1K | -$293.6K |
| Q1 2025 | -$197K | -110% |
| Q4 2024 | -$122.7K | +$1.6M |
FATN has burned cash in most quarters: −$589,364 over the past year, against −$526,884 the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
FATN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +35.4K shares |
| 1 year | +1.7% | +235K shares |
FATN has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
FATN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.3x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 0.5x | Very low |
FATN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
FATN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.4 | Neutral |
| Stochastic | 18.5 | Oversold |
FATN's weekly RSI is 48 (neutral) and its Stochastic is 19 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
FATN PE vs Technology Sector
| Metric | FATN | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 28x | 65% below |
| PE % | 2 | 24 | 22 pts below |
FATN is trading at 9.7x earnings, a 65% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
FATN has stronger trend alignment. ASTS is above 1 of 5 weekly averages versus FATN above 1 of 3.
FATN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.07 | 7.9% below |
| 20 week MA | $5.47 | 15% below |
| 50 week MA | $3.98 | 17% above |
FATN has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 17% above its 50-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
FATN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $6.36 | $2.51 | -61% |
| 2026 YTD | $2.51 | $4.67 | +86% |
FATN has the edge over ASTS on returns for 2026, with the stronger performance.